Al Zaidi Muteb, Wright Gavin M
Department of Cardiothoracic Surgery, St. Vincent's Hospital (Melbourne), University of Melbourne, Fitzroy, Victoria, Australia.
Division of Thoracic Surgery, King Abdullah Medical City, Makkah, Saudi Arabia.
Transl Lung Cancer Res. 2020 Aug;9(4):1680-1689. doi: 10.21037/tlcr.2019.11.22.
One reason that lung cancer is the leading cause of cancer mortality worldwide, is that surgical intervention is highly dependent on earlier tumor stage and good patient condition. As large proportion of cases are already metastatic at presentation and many are locally advanced, curative surgery is only possible in a minority of fit patients. Increasing the number of patients achieving complete resection is one of the avenues to increase overall survival using our existing technology. In the past, complex cases may have been sporadically discussed between various specialists in order to achieve better outcomes. More recently, the idea of discussing those cases on a routine basis, rather than an accident of geography or referral pattern, gave rise to the multidisciplinary team. Lung cancer management is now increasingly complex, especially with novel modalities such as targeted therapies, immune checkpoint inhibitors and stereotactic body radiotherapy delivery. Likewise, in thoracic surgery, minimally invasive techniques, early recovery after surgery protocols and complex techniques for resecting locally advanced tumours or preserving lung parenchyma must all be deployed appropriately to continue our incremental gains in survival and quality of life. To highlight the role of specialist thoracic surgeon in the multidisciplinary care of locally advanced non-small cell lung cancer, we conducted a search of English language publications for its multidisciplinary-based surgical management. We limited our search to the last decade, then hand-searched relevant references. In addition, we used our large prospective database as a team-oriented specialized thoracic surgical service to benchmark and demonstrate the benefits of specialist surgeons in the modern multidisciplinary team. In conclusion, patients with locally advanced non-small cell lung cancer should have any surgical option withheld without a specialist thoracic surgical opinion as part of the multidisciplinary team discussion.
肺癌是全球癌症死亡的主要原因之一,原因在于手术干预高度依赖肿瘤的早期阶段和患者的良好身体状况。由于很大一部分病例在确诊时已经发生转移,且许多病例为局部晚期,因此只有少数身体状况适宜的患者能够进行根治性手术。利用现有技术增加实现完全切除的患者数量是提高总体生存率的途径之一。过去,为了取得更好的治疗效果,不同专科医生之间可能会偶尔讨论复杂病例。最近,定期讨论这些病例的想法,而非基于地理位置或转诊模式的偶然情况,催生了多学科团队。肺癌的治疗如今日益复杂,尤其是在使用靶向治疗、免疫检查点抑制剂和立体定向体部放疗等新方法时。同样,在胸外科手术中,必须适当采用微创技术、术后早期恢复方案以及切除局部晚期肿瘤或保留肺实质的复杂技术,以持续提高生存率和生活质量。为了突出专科胸外科医生在局部晚期非小细胞肺癌多学科治疗中的作用,我们检索了英文出版物中基于多学科的手术治疗方法。我们将检索范围限制在过去十年,然后人工检索相关参考文献。此外,我们利用我们的大型前瞻性数据库,作为一个以团队为导向的专科胸外科服务,来衡量并展示专科外科医生在现代多学科团队中的益处。总之,作为多学科团队讨论的一部分,对于局部晚期非小细胞肺癌患者,如果没有专科胸外科医生的意见,不应提供任何手术选择。